APO Research
Talk to an analyst

APO RESEARCH · REPORT

Defibrinated Horse Blood

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Defibrinated Horse Blood Market Outlook and Growth Opportunities 2026

8 January 2026216 pages

Choose your research edition.

Industry ResearchDefibrinated Horse Blood Industry Research Report 2026149 pages · $2,950 USDIndustry Growth & TrendsGlobal Defibrinated Horse Blood Industry Growth and Trends Forecast to 2032122 pages · $3,450 USDMarket StructureGlobal Defibrinated Horse Blood Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032195 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Defibrinated Horse Blood Market Outlook and Growth Opportunities 2026216 pages · $4,250 USDMarket Analysis & ForecastGlobal Defibrinated Horse Blood Market Analysis and Forecast 2026-2032211 pages · $4,950 USD

Market perspective

The global Defibrinated Horse Blood market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Defibrinated Horse Blood is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Defibrinated Horse Blood is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Defibrinated Horse Blood is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Defibrinated Horse Blood market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Defibrinated Horse Blood market include Thermo Fisher Scientific, TCS Biosciences, BioMérieux, E & O Laboratories Ltd, Southern Biological, Biowest(BioNordic A/S), Pel-Freez Biologicals, Trafalgar Scientific and HemoStat Laboratories, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Defibrinated Horse Blood market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Defibrinated Horse Blood and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Defibrinated Horse Blood sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Defibrinated Horse Blood market size, projected growth trends, production technologies, key applications, and end-use industries.

Defibrinated Horse Blood Segment by Company

Thermo Fisher Scientific

TCS Biosciences

BioMérieux

E & O Laboratories Ltd

Southern Biological

Biowest(BioNordic A/S)

Pel-Freez Biologicals

Trafalgar Scientific

HemoStat Laboratories

EWC Diagnostics

Dutscher

Serana Europe

Kraeber & Co. GmbH

Bio Nutrientes Do Brasil Ltda.

Lampire Biological Laboratories, Inc.

Innovative Research Inc

Colorado Serum

SSI Diagnostica

SR Group

Szabo-Scandic

Rockland Immunochemicals, Inc.

LABone Scientific Co.Ltd.

Quad Five(Materials Bio Inc.)

Guangzhou Ruite Biotechnology Co., Ltd.

Obio Technology (Shanghai) Corp., Ltd.

Beijing Solarbio Science & Technology Co.,Ltd.

Nanjing SenBeiJia Biological Technology Co., Ltd.

Defibrinated Horse Blood Segment by Type

50ml

100ml

250ml

500ml

Others

Defibrinated Horse Blood Segment by Application

Biomedicine

Research

Defibrinated Horse Blood Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Defibrinated Horse Blood status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Defibrinated Horse Blood market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Defibrinated Horse Blood significant trends, drivers, influence factors in global and regions.

6. To analyze Defibrinated Horse Blood competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Defibrinated Horse Blood market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Defibrinated Horse Blood and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Defibrinated Horse Blood.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Defibrinated Horse Blood market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Defibrinated Horse Blood industry.

Chapter 3: Detailed analysis of Defibrinated Horse Blood manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Defibrinated Horse Blood in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Defibrinated Horse Blood in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Defibrinated Horse Blood Industry Trends Table 2. Defibrinated Horse Blood Industry Drivers Table 3. Defibrinated Horse Blood Industry Opportunities and Challenges Table 4. Defibrinated Horse Blood Industry Restraints Table 5. Global Defibrinated Horse Blood Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Defibrinated Horse Blood Revenue Share by Company (2021-2026) Table 7. Global Defibrinated Horse Blood Sales Volume by Company (kL) & (2021-2026) Table 8. Global Defibrinated Horse Blood Sales Volume Share by Company (2021-2026) Table 9. Global Defibrinated Horse Blood Average Price (USD/L) of Company (2021-2026) Table 10. Global Defibrinated Horse Blood Company Ranking, (2024-2026) & (USD Million) Table 11. Global Defibrinated Horse Blood Key Company Manufacturing Base & Headquarters Table 12. Global Defibrinated Horse Blood Company, Product Type & Application Table 13. Global Defibrinated Horse Blood Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Defibrinated Horse Blood by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of 50ml Table 18. Significant Companies of 100ml Table 19. Significant Companies of 250ml Table 20. Significant Companies of 500ml Table 21. Significant Companies of Others Table 22. Global Defibrinated Horse Blood Sales Volume by Type 2021 VS 2025 VS 2032 (kL) Table 23. Global Defibrinated Horse Blood Sales Volume by Type (2021-2026) & (kL) Table 24. Global Defibrinated Horse Blood Sales Volume by Type (2027-2032) & (kL) Table 25. Global Defibrinated Horse Blood Sales Volume Share by Type (2021-2026) Table 26. Global Defibrinated Horse Blood Sales Volume Share by Type (2027-2032) Table 27. Global Defibrinated Horse Blood Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 28. Global Defibrinated Horse Blood Sales Value by Type (2021-2026) & (US$ Million) Table 29. Global Defibrinated Horse Blood Sales Value by Type (2027-2032) & (US$ Million) Table 30. Global Defibrinated Horse Blood Sales Value Share by Type (2021-2026) Table 31. Global Defibrinated Horse Blood Sales Value Share by Type (2027-2032) Table 32. Significant Companies of Biomedicine Table 33. Significant Companies of Research Table 34. Global Defibrinated Horse Blood Sales Volume by Application 2021 VS 2025 VS 2032 (kL) Table 35. Global Defibrinated Horse Blood Sales Volume by Application (2021-2026) & (kL) Table 36. Global Defibrinated Horse Blood Sales Volume by Application (2027-2032) & (kL) Table 37. Global Defibrinated Horse Blood Sales Volume Share by Application (2021-2026) Table 38. Global Defibrinated Horse Blood Sales Volume Share by Application (2027-2032) Table 39. Global Defibrinated Horse Blood Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 40. Global Defibrinated Horse Blood Sales Value by Application (2021-2026) & (US$ Million) Table 41. Global Defibrinated Horse Blood Sales Value by Application (2027-2032) & (US$ Million) Table 42. Global Defibrinated Horse Blood Sales Value Share by Application (2021-2026) Table 43. Global Defibrinated Horse Blood Sales Value Share by Application (2027-2032) Table 44. Global Defibrinated Horse Blood Sales by Region: 2021 VS 2025 VS 2032 (kL) Table 45. Global Defibrinated Horse Blood Sales by Region (2021-2026) & (kL) Table 46. Global Defibrinated Horse Blood Sales Market Share by Region (2021-2026) Table 47. Global Defibrinated Horse Blood Sales by Region (2027-2032) & (kL) Table 48. Global Defibrinated Horse Blood Sales Market Share by Region (2027-2032) Table 49. Global Defibrinated Horse Blood Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 50. Global Defibrinated Horse Blood Sales Value by Region (2021-2026) & (US$ Million) Table 51. Global Defibrinated Horse Blood Sales Value Share by Region (2021-2026) Table 52. Global Defibrinated Horse Blood Sales Value by Region (2027-2032) & (US$ Million) Table 53. Global Defibrinated Horse Blood Sales Value Share by Region (2027-2032) Table 54. Global Defibrinated Horse Blood Market Average Price (USD/L) by Region (2021-2026) Table 55. Global Defibrinated Horse Blood Market Average Price (USD/L) by Region (2027-2032) Table 56. Global Defibrinated Horse Blood Sales by Country: 2021 VS 2025 VS 2032 (kL) Table 57. Global Defibrinated Horse Blood Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 58. Global Defibrinated Horse Blood Sales by Country (2021-2026) & (kL) Table 59. Global Defibrinated Horse Blood Sales Market Share by Country (2021-2026) Table 60. Global Defibrinated Horse Blood Sales by Country (2027-2032) & (kL) Table 61. Global Defibrinated Horse Blood Sales Market Share by Country (2027-2032) Table 62. Global Defibrinated Horse Blood Sales Value by Country (2021-2026) & (US$ Million) Table 63. Global Defibrinated Horse Blood Sales Value Market Share by Country (2021-2026) Table 64. Global Defibrinated Horse Blood Sales Value by Country (2027-2032) & (US$ Million) Table 65. Global Defibrinated Horse Blood Sales Value Market Share by Country (2027-2032) Table 66. Thermo Fisher Scientific Company Information Table 67. Thermo Fisher Scientific Business Overview Table 68. Thermo Fisher Scientific Defibrinated Horse Blood Sales (kL), Value (US$ Million), Price (USD/L) and Gross Margin (2021-2026) Table 69. Thermo Fisher Scientific Defibrinated Horse Blood Product Portfolio Table 70. Thermo Fisher Scientific Recent Development Table 71. TCS Biosciences Company Information Table 72. TCS Biosciences Business Overview Table 73. TCS Biosciences Defibrinated Horse Blood Sales (kL), Value (US$ Million), Price (USD/L) and Gross Margin (2021-2026) Table 74. TCS Biosciences Defibrinated Horse Blood Product Portfolio Table 75. TCS Biosciences Recent Development Table 76. BioMérieux Company Information Table 77. BioMérieux Business Overview Table 78. BioMérieux Defibrinated Horse Blood Sales (kL), Value (US$ Million), Price (USD/L) and Gross Margin (2021-2026) Table 79. BioMérieux Defibrinated Horse Blood Product Portfolio Table 80. BioMérieux Recent Development Table 81. E & O Laboratories Ltd Company Information Table 82. E & O Laboratories Ltd Business Overview Table 83. E & O Laboratories Ltd Defibrinated Horse Blood Sales (kL), Value (US$ Million), Price (USD/L) and Gross Margin (2021-2026) Table 84. E & O Laboratories Ltd Defibrinated Horse Blood Product Portfolio Table 85. E & O Laboratories Ltd Recent Development Table 86. Southern Biological Company Information Table 87. Southern Biological Business Overview Table 88. Southern Biological Defibrinated Horse Blood Sales (kL), Value (US$ Million), Price (USD/L) and Gross Margin (2021-2026) Table 89. Southern Biological Defibrinated Horse Blood Product Portfolio Table 90. Southern Biological Recent Development Table 91. Biowest(BioNordic A/S) Company Information Table 92. Biowest(BioNordic A/S) Business Overview Table 93. Biowest(BioNordic A/S) Defibrinated Horse Blood Sales (kL), Value (US$ Million), Price (USD/L) and Gross Margin (2021-2026) Table 94. Biowest(BioNordic A/S) Defibrinated Horse Blood Product Portfolio Table 95. Biowest(BioNordic A/S) Recent Development Table 96. Pel-Freez Biologicals Company Information Table 97. Pel-Freez Biologicals Business Overview Table 98. Pel-Freez Biologicals Defibrinated Horse Blood Sales (kL), Value (US$ Million), Price (USD/L) and Gross Margin (2021-2026) Table 99. Pel-Freez Biologicals Defibrinated Horse Blood Product Portfolio Table 100. Pel-Freez Biologicals Recent Development Table 101. Trafalgar Scientific Company Information Table 102. Trafalgar Scientific Business Overview Table 103. Trafalgar Scientific Defibrinated Horse Blood Sales (kL), Value (US$ Million), Price (USD/L) and Gross Margin (2021-2026) Table 104. Trafalgar Scientific Defibrinated Horse Blood Product Portfolio Table 105. Trafalgar Scientific Recent Development Table 106. HemoStat Laboratories Company Information Table 107. HemoStat Laboratories Business Overview Table 108. HemoStat Laboratories Defibrinated Horse Blood Sales (kL), Value (US$ Million), Price (USD/L) and Gross Margin (2021-2026) Table 109. HemoStat Laboratories Defibrinated Horse Blood Product Portfolio Table 110. HemoStat Laboratories Recent Development Table 111. EWC Diagnostics Company Information Table 112. EWC Diagnostics Business Overview Table 113. EWC Diagnostics Defibrinated Horse Blood Sales (kL), Value (US$ Million), Price (USD/L) and Gross Margin (2021-2026) Table 114. EWC Diagnostics Defibrinated Horse Blood Product Portfolio Table 115. EWC Diagnostics Recent Development Table 116. Dutscher Company Information Table 117. Dutscher Business Overview Table 118. Dutscher Defibrinated Horse Blood Sales (kL), Value (US$ Million), Price (USD/L) and Gross Margin (2021-2026) Table 119. Dutscher Defibrinated Horse Blood Product Portfolio Table 120. Dutscher Recent Development Table 121. Serana Europe Company Information Table 122. Serana Europe Business Overview Table 123. Serana Europe Defibrinated Horse Blood Sales (kL), Value (US$ Million), Price (USD/L) and Gross Margin (2021-2026) Table 124. Serana Europe Defibrinated Horse Blood Product Portfolio Table 125. Serana Europe Recent Development Table 126. Kraeber & Co. GmbH Company Information Table 127. Kraeber & Co. GmbH Business Overview Table 128. Kraeber & Co. GmbH Defibrinated Horse Blood Sales (kL), Value (US$ Million), Price (USD/L) and Gross Margin (2021-2026) Table 129. Kraeber & Co. GmbH Defibrinated Horse Blood Product Portfolio Table 130. Kraeber & Co. GmbH Recent Development Table 131. Bio Nutrientes Do Brasil Ltda. Company Information Table 132. Bio Nutrientes Do Brasil Ltda. Business Overview Table 133. Bio Nutrientes Do Brasil Ltda. Defibrinated Horse Blood Sales (kL), Value (US$ Million), Price (USD/L) and Gross Margin (2021-2026) Table 134. Bio Nutrientes Do Brasil Ltda. Defibrinated Horse Blood Product Portfolio Table 135. Bio Nutrientes Do Brasil Ltda. Recent Development Table 136. Lampire Biological Laboratories, Inc. Company Information Table 137. Lampire Biological Laboratories, Inc. Business Overview Table 138. Lampire Biological Laboratories, Inc. Defibrinated Horse Blood Sales (kL), Value (US$ Million), Price (USD/L) and Gross Margin (2021-2026) Table 139. Lampire Biological Laboratories, Inc. Defibrinated Horse Blood Product Portfolio Table 140. Lampire Biological Laboratories, Inc. Recent Development Table 141. Innovative Research Inc Company Information Table 142. Innovative Research Inc Business Overview Table 143. Innovative Research Inc Defibrinated Horse Blood Sales (kL), Value (US$ Million), Price (USD/L) and Gross Margin (2021-2026) Table 144. Innovative Research Inc Defibrinated Horse Blood Product Portfolio Table 145. Innovative Research Inc Recent Development Table 146. Colorado Serum Company Information Table 147. Colorado Serum Business Overview Table 148. Colorado Serum Defibrinated Horse Blood Sales (kL), Value (US$ Million), Price (USD/L) and Gross Margin (2021-2026) Table 149. Colorado Serum Defibrinated Horse Blood Product Portfolio Table 150. Colorado Serum Recent Development Table 151. SSI Diagnostica Company Information Table 152. SSI Diagnostica Business Overview Table 153. SSI Diagnostica Defibrinated Horse Blood Sales (kL), Value (US$ Million), Price (USD/L) and Gross Margin (2021-2026) Table 154. SSI Diagnostica Defibrinated Horse Blood Product Portfolio Table 155. SSI Diagnostica Recent Development Table 156. SR Group Company Information Table 157. SR Group Business Overview Table 158. SR Group Defibrinated Horse Blood Sales (kL), Value (US$ Million), Price (USD/L) and Gross Margin (2021-2026) Table 159. SR Group Defibrinated Horse Blood Product Portfolio Table 160. SR Group Recent Development Table 161. Szabo-Scandic Company Information Table 162. Szabo-Scandic Business Overview Table 163. Szabo-Scandic Defibrinated Horse Blood Sales (kL), Value (US$ Million), Price (USD/L) and Gross Margin (2021-2026) Table 164. Szabo-Scandic Defibrinated Horse Blood Product Portfolio Table 165. Szabo-Scandic Recent Development Table 166. Rockland Immunochemicals, Inc. Company Information Table 167. Rockland Immunochemicals, Inc. Business Overview Table 168. Rockland Immunochemicals, Inc. Defibrinated Horse Blood Sales (kL), Value (US$ Million), Price (USD/L) and Gross Margin (2021-2026) Table 169. Rockland Immunochemicals, Inc. Defibrinated Horse Blood Product Portfolio Table 170. Rockland Immunochemicals, Inc. Recent Development Table 171. LABone Scientific Co.Ltd. Company Information Table 172. LABone Scientific Co.Ltd. Business Overview Table 173. LABone Scientific Co.Ltd. Defibrinated Horse Blood Sales (kL), Value (US$ Million), Price (USD/L) and Gross Margin (2021-2026) Table 174. LABone Scientific Co.Ltd. Defibrinated Horse Blood Product Portfolio Table 175. LABone Scientific Co.Ltd. Recent Development Table 176. Quad Five(Materials Bio Inc.) Company Information Table 177. Quad Five(Materials Bio Inc.) Business Overview Table 178. Quad Five(Materials Bio Inc.) Defibrinated Horse Blood Sales (kL), Value (US$ Million), Price (USD/L) and Gross Margin (2021-2026) Table 179. Quad Five(Materials Bio Inc.) Defibrinated Horse Blood Product Portfolio Table 180. Quad Five(Materials Bio Inc.) Recent Development Table 181. Guangzhou Ruite Biotechnology Co., Ltd. Company Information Table 182. Guangzhou Ruite Biotechnology Co., Ltd. Business Overview Table 183. Guangzhou Ruite Biotechnology Co., Ltd. Defibrinated Horse Blood Sales (kL), Value (US$ Million), Price (USD/L) and Gross Margin (2021-2026) Table 184. Guangzhou Ruite Biotechnology Co., Ltd. Defibrinated Horse Blood Product Portfolio Table 185. Guangzhou Ruite Biotechnology Co., Ltd. Recent Development Table 186. Obio Technology (Shanghai) Corp., Ltd. Company Information Table 187. Obio Technology (Shanghai) Corp., Ltd. Business Overview Table 188. Obio Technology (Shanghai) Corp., Ltd. Defibrinated Horse Blood Sales (kL), Value (US$ Million), Price (USD/L) and Gross Margin (2021-2026) Table 189. Obio Technology (Shanghai) Corp., Ltd. Defibrinated Horse Blood Product Portfolio Table 190. Obio Technology (Shanghai) Corp., Ltd. Recent Development Table 191. Beijing Solarbio Science & Technology Co.,Ltd. Company Information Table 192. Beijing Solarbio Science & Technology Co.,Ltd. Business Overview Table 193. Beijing Solarbio Science & Technology Co.,Ltd. Defibrinated Horse Blood Sales (kL), Value (US$ Million), Price (USD/L) and Gross Margin (2021-2026) Table 194. Beijing Solarbio Science & Technology Co.,Ltd. Defibrinated Horse Blood Product Portfolio Table 195. Beijing Solarbio Science & Technology Co.,Ltd. Recent Development Table 196. Nanjing SenBeiJia Biological Technology Co., Ltd. Company Information Table 197. Nanjing SenBeiJia Biological Technology Co., Ltd. Business Overview Table 198. Nanjing SenBeiJia Biological Technology Co., Ltd. Defibrinated Horse Blood Sales (kL), Value (US$ Million), Price (USD/L) and Gross Margin (2021-2026) Table 199. Nanjing SenBeiJia Biological Technology Co., Ltd. Defibrinated Horse Blood Product Portfolio Table 200. Nanjing SenBeiJia Biological Technology Co., Ltd. Recent Development Table 201. Key Raw Materials Table 202. Raw Materials Key Suppliers Table 203. Defibrinated Horse Blood Distributors List Table 204. Defibrinated Horse Blood Customers List Table 205. Research Programs/Design for This Report Table 206. Authors List of This Report Table 207. Secondary Sources Table 208. Primary Sources List of Figures Figure 1. Defibrinated Horse Blood Product Image Figure 2. Global Defibrinated Horse Blood Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Defibrinated Horse Blood Sales Value (2021-2032) & (US$ Million) Figure 4. Global Defibrinated Horse Blood Sales (2021-2032) & (kL) Figure 5. Global Defibrinated Horse Blood Sales Average Price (USD/L) & (2021-2032) Figure 6. Global Defibrinated Horse Blood Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. 50ml Image Figure 10. 100ml Image Figure 11. 250ml Image Figure 12. 500ml Image Figure 13. Others Image Figure 14. Global Defibrinated Horse Blood Sales Volume by Type (2021 VS 2025 VS 2032) & (kL) Figure 15. Global Defibrinated Horse Blood Sales Volume Share 2021 VS 2025 VS 2032 Figure 16. Global Defibrinated Horse Blood Sales Volume Share by Type (2021-2032) Figure 17. Global Defibrinated Horse Blood Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 18. Global Defibrinated Horse Blood Sales Value Share 2021 VS 2025 VS 2032 Figure 19. Global Defibrinated Horse Blood Sales Value Share by Type (2021-2032) Figure 20. Biomedicine Image Figure 21. Research Image Figure 22. Global Defibrinated Horse Blood Sales Volume by Application (2021 VS 2025 VS 2032) & (kL) Figure 23. Global Defibrinated Horse Blood Sales Volume Share 2021 VS 2025 VS 2032 Figure 24. Global Defibrinated Horse Blood Sales Volume Share by Application (2021-2032) Figure 25. Global Defibrinated Horse Blood Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 26. Global Defibrinated Horse Blood Sales Value Share 2021 VS 2025 VS 2032 Figure 27. Global Defibrinated Horse Blood Sales Value Share by Application (2021-2032) Figure 28. Global Defibrinated Horse Blood Sales by Region: 2021 VS 2025 VS 2032 (kL) Figure 29. Global Defibrinated Horse Blood Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 30. Global Defibrinated Horse Blood Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 31. Global Defibrinated Horse Blood Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 32. North America Defibrinated Horse Blood Sales Value (2021-2032) & (US$ Million) Figure 33. North America Defibrinated Horse Blood Sales Value Share by Country (%), 2025 VS 2032 Figure 34. Europe Defibrinated Horse Blood Sales Value (2021-2032) & (US$ Million) Figure 35. Europe Defibrinated Horse Blood Sales Value Share by Country (%), 2025 VS 2032 Figure 36. Asia-Pacific Defibrinated Horse Blood Sales Value (2021-2032) & (US$ Million) Figure 37. Asia-Pacific Defibrinated Horse Blood Sales Value Share by Country (%), 2025 VS 2032 Figure 38. South America Defibrinated Horse Blood Sales Value (2021-2032) & (US$ Million) Figure 39. South America Defibrinated Horse Blood Sales Value Share by Country (%), 2025 VS 2032 Figure 40. Middle East & Africa Defibrinated Horse Blood Sales Value (2021-2032) & (US$ Million) Figure 41. Middle East & Africa Defibrinated Horse Blood Sales Value Share by Country (%), 2025 VS 2032 Figure 42. USA Defibrinated Horse Blood Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 43. USA Defibrinated Horse Blood Sales Value Share by Type, 2025 VS 2032 & (%) Figure 44. USA Defibrinated Horse Blood Sales Value Share by Application, 2025 VS 2032 & (%) Figure 45. Canada Defibrinated Horse Blood Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 46. Canada Defibrinated Horse Blood Sales Value Share by Type, 2025 VS 2032 & (%) Figure 47. Canada Defibrinated Horse Blood Sales Value Share by Application, 2025 VS 2032 & (%) Figure 48. Mexico Defibrinated Horse Blood Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 49. Mexico Defibrinated Horse Blood Sales Value Share by Type, 2025 VS 2032 & (%) Figure 50. Mexico Defibrinated Horse Blood Sales Value Share by Application, 2025 VS 2032 & (%) Figure 51. Germany Defibrinated Horse Blood Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 52. Germany Defibrinated Horse Blood Sales Value Share by Type, 2025 VS 2032 & (%) Figure 53. Germany Defibrinated Horse Blood Sales Value Share by Application, 2025 VS 2032 & (%) Figure 54. France Defibrinated Horse Blood Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 55. France Defibrinated Horse Blood Sales Value Share by Type, 2025 VS 2032 & (%) Figure 56. France Defibrinated Horse Blood Sales Value Share by Application, 2025 VS 2032 & (%) Figure 57. U.K. Defibrinated Horse Blood Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 58. U.K. Defibrinated Horse Blood Sales Value Share by Type, 2025 VS 2032 & (%) Figure 59. U.K. Defibrinated Horse Blood Sales Value Share by Application, 2025 VS 2032 & (%) Figure 60. Italy Defibrinated Horse Blood Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 61. Italy Defibrinated Horse Blood Sales Value Share by Type, 2025 VS 2032 & (%) Figure 62. Italy Defibrinated Horse Blood Sales Value Share by Application, 2025 VS 2032 & (%) Figure 63. Spain Defibrinated Horse Blood Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 64. Spain Defibrinated Horse Blood Sales Value Share by Type, 2025 VS 2032 & (%) Figure 65. Spain Defibrinated Horse Blood Sales Value Share by Application, 2025 VS 2032 & (%) Figure 66. Russia Defibrinated Horse Blood Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 67. Russia Defibrinated Horse Blood Sales Value Share by Type, 2025 VS 2032 & (%) Figure 68. Russia Defibrinated Horse Blood Sales Value Share by Application, 2025 VS 2032 & (%) Figure 69. Netherlands Defibrinated Horse Blood Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 70. Netherlands Defibrinated Horse Blood Sales Value Share by Type, 2025 VS 2032 & (%) Figure 71. Netherlands Defibrinated Horse Blood Sales Value Share by Application, 2025 VS 2032 & (%) Figure 72. Nordic Countries Defibrinated Horse Blood Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 73. Nordic Countries Defibrinated Horse Blood Sales Value Share by Type, 2025 VS 2032 & (%) Figure 74. Nordic Countries Defibrinated Horse Blood Sales Value Share by Application, 2025 VS 2032 & (%) Figure 75. China Defibrinated Horse Blood Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 76. China Defibrinated Horse Blood Sales Value Share by Type, 2025 VS 2032 & (%) Figure 77. China Defibrinated Horse Blood Sales Value Share by Application, 2025 VS 2032 & (%) Figure 78. Japan Defibrinated Horse Blood Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 79. Japan Defibrinated Horse Blood Sales Value Share by Type, 2025 VS 2032 & (%) Figure 80. Japan Defibrinated Horse Blood Sales Value Share by Application, 2025 VS 2032 & (%) Figure 81. South Korea Defibrinated Horse Blood Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 82. South Korea Defibrinated Horse Blood Sales Value Share by Type, 2025 VS 2032 & (%) Figure 83. South Korea Defibrinated Horse Blood Sales Value Share by Application, 2025 VS 2032 & (%) Figure 84. India Defibrinated Horse Blood Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 85. India Defibrinated Horse Blood Sales Value Share by Type, 2025 VS 2032 & (%) Figure 86. India Defibrinated Horse Blood Sales Value Share by Application, 2025 VS 2032 & (%) Figure 87. Australia Defibrinated Horse Blood Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 88. Australia Defibrinated Horse Blood Sales Value Share by Type, 2025 VS 2032 & (%) Figure 89. Australia Defibrinated Horse Blood Sales Value Share by Application, 2025 VS 2032 & (%) Figure 90. Southeast Asia Defibrinated Horse Blood Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 91. Southeast Asia Defibrinated Horse Blood Sales Value Share by Type, 2025 VS 2032 & (%) Figure 92. Southeast Asia Defibrinated Horse Blood Sales Value Share by Application, 2025 VS 2032 & (%) Figure 93. Brazil Defibrinated Horse Blood Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 94. Brazil Defibrinated Horse Blood Sales Value Share by Type, 2025 VS 2032 & (%) Figure 95. Brazil Defibrinated Horse Blood Sales Value Share by Application, 2025 VS 2032 & (%) Figure 96. Argentina Defibrinated Horse Blood Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 97. Argentina Defibrinated Horse Blood Sales Value Share by Type, 2025 VS 2032 & (%) Figure 98. Argentina Defibrinated Horse Blood Sales Value Share by Application, 2025 VS 2032 & (%) Figure 99. Chile Defibrinated Horse Blood Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 100. Chile Defibrinated Horse Blood Sales Value Share by Type, 2025 VS 2032 & (%) Figure 101. Chile Defibrinated Horse Blood Sales Value Share by Application, 2025 VS 2032 & (%) Figure 102. Colombia Defibrinated Horse Blood Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 103. Colombia Defibrinated Horse Blood Sales Value Share by Type, 2025 VS 2032 & (%) Figure 104. Colombia Defibrinated Horse Blood Sales Value Share by Application, 2025 VS 2032 & (%) Figure 105. Peru Defibrinated Horse Blood Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 106. Peru Defibrinated Horse Blood Sales Value Share by Type, 2025 VS 2032 & (%) Figure 107. Peru Defibrinated Horse Blood Sales Value Share by Application, 2025 VS 2032 & (%) Figure 108. Saudi Arabia Defibrinated Horse Blood Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 109. Saudi Arabia Defibrinated Horse Blood Sales Value Share by Type, 2025 VS 2032 & (%) Figure 110. Saudi Arabia Defibrinated Horse Blood Sales Value Share by Application, 2025 VS 2032 & (%) Figure 111. Israel Defibrinated Horse Blood Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 112. Israel Arabia Defibrinated Horse Blood Sales Value Share by Type, 2025 VS 2032 & (%) Figure 113. Israel Arabia Defibrinated Horse Blood Sales Value Share by Application, 2025 VS 2032 & (%) Figure 114. UAE Defibrinated Horse Blood Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 115. UAE Defibrinated Horse Blood Sales Value Share by Type, 2025 VS 2032 & (%) Figure 116. UAE Defibrinated Horse Blood Sales Value Share by Application, 2025 VS 2032 & (%) Figure 117. Turkey Defibrinated Horse Blood Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 118. Turkey Defibrinated Horse Blood Sales Value Share by Type, 2025 VS 2032 & (%) Figure 119. Turkey Defibrinated Horse Blood Sales Value Share by Application, 2025 VS 2032 & (%) Figure 120. Iran Defibrinated Horse Blood Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 121. Iran Defibrinated Horse Blood Sales Value Share by Type, 2025 VS 2032 & (%) Figure 122. Iran Defibrinated Horse Blood Sales Value Share by Application, 2025 VS 2032 & (%) Figure 123. Egypt Defibrinated Horse Blood Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 124. Egypt Defibrinated Horse Blood Sales Value Share by Type, 2025 VS 2032 & (%) Figure 125. Egypt Defibrinated Horse Blood Sales Value Share by Application, 2025 VS 2032 & (%) Figure 126. Defibrinated Horse Blood Value Chain Figure 127. Manufacturing Cost Structure Figure 128. Defibrinated Horse Blood Sales Mode & Process Figure 129. Direct Comparison with Distribution Share Figure 130. Distributors Profiles Figure 131. Years Considered Figure 132. Research Process Figure 133. Key Executives Interviewed

Scope & coverage.

Types
  • 50ml
  • 100ml
  • 250ml
  • 500ml
  • Others
Applications
  • Biomedicine
  • Research
Companies covered
  • Thermo Fisher Scientific
  • TCS Biosciences
  • BioMérieux
  • E & O Laboratories Ltd
  • Southern Biological
  • Biowest(BioNordic A/S)
  • Pel-Freez Biologicals
  • Trafalgar Scientific
  • HemoStat Laboratories
  • EWC Diagnostics
  • Dutscher
  • Serana Europe
  • Kraeber & Co. GmbH
  • Bio Nutrientes Do Brasil Ltda.
  • Lampire Biological Laboratories, Inc.
  • Innovative Research Inc
  • Colorado Serum
  • SSI Diagnostica
  • SR Group
  • Szabo-Scandic
  • Rockland Immunochemicals, Inc.
  • LABone Scientific Co.Ltd.
  • Quad Five(Materials Bio Inc.)
  • Guangzhou Ruite Biotechnology Co., Ltd.
  • Obio Technology (Shanghai) Corp., Ltd.
  • Beijing Solarbio Science & Technology Co.,Ltd.
  • Nanjing SenBeiJia Biological Technology Co., Ltd.

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Defibrinated Horse Blood Sales Value (2021-2032)
  4. 1.2.2 Global Defibrinated Horse Blood Sales Volume (2021-2032)
  5. 1.2.3 Global Defibrinated Horse Blood Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Defibrinated Horse Blood Market Dynamics
  1. 2.1 Defibrinated Horse Blood Industry Trends
  2. 2.2 Defibrinated Horse Blood Industry Drivers
  3. 2.3 Defibrinated Horse Blood Industry Opportunities and Challenges
  4. 2.4 Defibrinated Horse Blood Industry Restraints
3 Defibrinated Horse Blood Market by Company
  1. 3.1 Global Defibrinated Horse Blood Company Revenue Ranking in 2025
  2. 3.2 Global Defibrinated Horse Blood Revenue by Company (2021-2026)
  3. 3.3 Global Defibrinated Horse Blood Sales Volume by Company (2021-2026)
  4. 3.4 Global Defibrinated Horse Blood Average Price by Company (2021-2026)
  5. 3.5 Global Defibrinated Horse Blood Company Ranking (2024-2026)
  6. 3.6 Global Defibrinated Horse Blood Company Manufacturing Base and Headquarters
  7. 3.7 Global Defibrinated Horse Blood Company Product Type and Application
  8. 3.8 Global Defibrinated Horse Blood Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Defibrinated Horse Blood Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Defibrinated Horse Blood Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Defibrinated Horse Blood Market by Type
  1. 4.1 Defibrinated Horse Blood Type Introduction
  2. 4.1.1 50ml
  3. 4.1.2 100ml
  4. 4.1.3 250ml
  5. 4.1.4 500ml
  6. 4.1.5 Others
  7. 4.2 Global Defibrinated Horse Blood Sales Volume by Type
  8. 4.2.1 Global Defibrinated Horse Blood Sales Volume by Type (2021 VS 2025 VS 2032)
  9. 4.2.2 Global Defibrinated Horse Blood Sales Volume by Type (2021-2032)
  10. 4.2.3 Global Defibrinated Horse Blood Sales Volume Share by Type (2021-2032)
  11. 4.3 Global Defibrinated Horse Blood Sales Value by Type
  12. 4.3.1 Global Defibrinated Horse Blood Sales Value by Type (2021 VS 2025 VS 2032)
  13. 4.3.2 Global Defibrinated Horse Blood Sales Value by Type (2021-2032)
  14. 4.3.3 Global Defibrinated Horse Blood Sales Value Share by Type (2021-2032)
5 Defibrinated Horse Blood Market by Application
  1. 5.1 Defibrinated Horse Blood Application Introduction
  2. 5.1.1 Biomedicine
  3. 5.1.2 Research
  4. 5.2 Global Defibrinated Horse Blood Sales Volume by Application
  5. 5.2.1 Global Defibrinated Horse Blood Sales Volume by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global Defibrinated Horse Blood Sales Volume by Application (2021-2032)
  7. 5.2.3 Global Defibrinated Horse Blood Sales Volume Share by Application (2021-2032)
  8. 5.3 Global Defibrinated Horse Blood Sales Value by Application
  9. 5.3.1 Global Defibrinated Horse Blood Sales Value by Application (2021 VS 2025 VS 2032)
  10. 5.3.2 Global Defibrinated Horse Blood Sales Value by Application (2021-2032)
  11. 5.3.3 Global Defibrinated Horse Blood Sales Value Share by Application (2021-2032)
6 Defibrinated Horse Blood Regional Sales and Value Analysis
  1. 6.1 Global Defibrinated Horse Blood Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Defibrinated Horse Blood Sales by Region (2021-2032)
  3. 6.2.1 Global Defibrinated Horse Blood Sales by Region: 2021-2026
  4. 6.2.2 Global Defibrinated Horse Blood Sales by Region (2027-2032)
  5. 6.3 Global Defibrinated Horse Blood Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Defibrinated Horse Blood Sales Value by Region (2021-2032)
  7. 6.4.1 Global Defibrinated Horse Blood Sales Value by Region: 2021-2026
  8. 6.4.2 Global Defibrinated Horse Blood Sales Value by Region (2027-2032)
  9. 6.5 Global Defibrinated Horse Blood Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Defibrinated Horse Blood Sales Value (2021-2032)
  12. 6.6.2 North America Defibrinated Horse Blood Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Defibrinated Horse Blood Sales Value (2021-2032)
  15. 6.7.2 Europe Defibrinated Horse Blood Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Defibrinated Horse Blood Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Defibrinated Horse Blood Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Defibrinated Horse Blood Sales Value (2021-2032)
  21. 6.9.2 South America Defibrinated Horse Blood Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Defibrinated Horse Blood Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Defibrinated Horse Blood Sales Value Share by Country, 2025 VS 2032
7 Defibrinated Horse Blood Country-level Sales and Value Analysis
  1. 7.1 Global Defibrinated Horse Blood Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Defibrinated Horse Blood Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Defibrinated Horse Blood Sales by Country (2021-2032)
  4. 7.3.1 Global Defibrinated Horse Blood Sales by Country (2021-2026)
  5. 7.3.2 Global Defibrinated Horse Blood Sales by Country (2027-2032)
  6. 7.4 Global Defibrinated Horse Blood Sales Value by Country (2021-2032)
  7. 7.4.1 Global Defibrinated Horse Blood Sales Value by Country (2021-2026)
  8. 7.4.2 Global Defibrinated Horse Blood Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Defibrinated Horse Blood Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Defibrinated Horse Blood Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Defibrinated Horse Blood Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Defibrinated Horse Blood Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Defibrinated Horse Blood Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Defibrinated Horse Blood Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Defibrinated Horse Blood Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Defibrinated Horse Blood Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Defibrinated Horse Blood Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Defibrinated Horse Blood Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Defibrinated Horse Blood Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Defibrinated Horse Blood Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Defibrinated Horse Blood Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Defibrinated Horse Blood Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Defibrinated Horse Blood Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Defibrinated Horse Blood Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Defibrinated Horse Blood Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Defibrinated Horse Blood Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Defibrinated Horse Blood Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Defibrinated Horse Blood Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Defibrinated Horse Blood Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Defibrinated Horse Blood Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Defibrinated Horse Blood Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Defibrinated Horse Blood Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Defibrinated Horse Blood Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Defibrinated Horse Blood Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Defibrinated Horse Blood Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Defibrinated Horse Blood Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Defibrinated Horse Blood Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Defibrinated Horse Blood Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Defibrinated Horse Blood Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Defibrinated Horse Blood Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Defibrinated Horse Blood Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Defibrinated Horse Blood Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Defibrinated Horse Blood Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Defibrinated Horse Blood Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Defibrinated Horse Blood Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Defibrinated Horse Blood Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Defibrinated Horse Blood Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Defibrinated Horse Blood Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Defibrinated Horse Blood Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Defibrinated Horse Blood Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Defibrinated Horse Blood Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Defibrinated Horse Blood Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Defibrinated Horse Blood Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Defibrinated Horse Blood Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Defibrinated Horse Blood Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Defibrinated Horse Blood Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Defibrinated Horse Blood Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Defibrinated Horse Blood Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Defibrinated Horse Blood Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Defibrinated Horse Blood Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Defibrinated Horse Blood Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Defibrinated Horse Blood Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Defibrinated Horse Blood Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Defibrinated Horse Blood Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Defibrinated Horse Blood Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Defibrinated Horse Blood Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Defibrinated Horse Blood Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Defibrinated Horse Blood Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Defibrinated Horse Blood Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Defibrinated Horse Blood Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Defibrinated Horse Blood Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Defibrinated Horse Blood Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Defibrinated Horse Blood Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Defibrinated Horse Blood Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Defibrinated Horse Blood Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Defibrinated Horse Blood Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Defibrinated Horse Blood Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Defibrinated Horse Blood Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Defibrinated Horse Blood Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Defibrinated Horse Blood Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Defibrinated Horse Blood Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Defibrinated Horse Blood Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Defibrinated Horse Blood Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Defibrinated Horse Blood Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Defibrinated Horse Blood Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Defibrinated Horse Blood Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Defibrinated Horse Blood Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Defibrinated Horse Blood Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Defibrinated Horse Blood Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Defibrinated Horse Blood Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Defibrinated Horse Blood Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Defibrinated Horse Blood Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Thermo Fisher Scientific
  2. 8.1.1 Thermo Fisher Scientific Company Information
  3. 8.1.2 Thermo Fisher Scientific Business Overview
  4. 8.1.3 Thermo Fisher Scientific Defibrinated Horse Blood Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Thermo Fisher Scientific Defibrinated Horse Blood Product Portfolio
  6. 8.1.5 Thermo Fisher Scientific Recent Developments
  7. 8.2 TCS Biosciences
  8. 8.2.1 TCS Biosciences Company Information
  9. 8.2.2 TCS Biosciences Business Overview
  10. 8.2.3 TCS Biosciences Defibrinated Horse Blood Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 TCS Biosciences Defibrinated Horse Blood Product Portfolio
  12. 8.2.5 TCS Biosciences Recent Developments
  13. 8.3 BioMérieux
  14. 8.3.1 BioMérieux Company Information
  15. 8.3.2 BioMérieux Business Overview
  16. 8.3.3 BioMérieux Defibrinated Horse Blood Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 BioMérieux Defibrinated Horse Blood Product Portfolio
  18. 8.3.5 BioMérieux Recent Developments
  19. 8.4 E & O Laboratories Ltd
  20. 8.4.1 E & O Laboratories Ltd Company Information
  21. 8.4.2 E & O Laboratories Ltd Business Overview
  22. 8.4.3 E & O Laboratories Ltd Defibrinated Horse Blood Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 E & O Laboratories Ltd Defibrinated Horse Blood Product Portfolio
  24. 8.4.5 E & O Laboratories Ltd Recent Developments
  25. 8.5 Southern Biological
  26. 8.5.1 Southern Biological Company Information
  27. 8.5.2 Southern Biological Business Overview
  28. 8.5.3 Southern Biological Defibrinated Horse Blood Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Southern Biological Defibrinated Horse Blood Product Portfolio
  30. 8.5.5 Southern Biological Recent Developments
  31. 8.6 Biowest(BioNordic A/S)
  32. 8.6.1 Biowest(BioNordic A/S) Company Information
  33. 8.6.2 Biowest(BioNordic A/S) Business Overview
  34. 8.6.3 Biowest(BioNordic A/S) Defibrinated Horse Blood Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Biowest(BioNordic A/S) Defibrinated Horse Blood Product Portfolio
  36. 8.6.5 Biowest(BioNordic A/S) Recent Developments
  37. 8.7 Pel-Freez Biologicals
  38. 8.7.1 Pel-Freez Biologicals Company Information
  39. 8.7.2 Pel-Freez Biologicals Business Overview
  40. 8.7.3 Pel-Freez Biologicals Defibrinated Horse Blood Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 Pel-Freez Biologicals Defibrinated Horse Blood Product Portfolio
  42. 8.7.5 Pel-Freez Biologicals Recent Developments
  43. 8.8 Trafalgar Scientific
  44. 8.8.1 Trafalgar Scientific Company Information
  45. 8.8.2 Trafalgar Scientific Business Overview
  46. 8.8.3 Trafalgar Scientific Defibrinated Horse Blood Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 Trafalgar Scientific Defibrinated Horse Blood Product Portfolio
  48. 8.8.5 Trafalgar Scientific Recent Developments
  49. 8.9 HemoStat Laboratories
  50. 8.9.1 HemoStat Laboratories Company Information
  51. 8.9.2 HemoStat Laboratories Business Overview
  52. 8.9.3 HemoStat Laboratories Defibrinated Horse Blood Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 HemoStat Laboratories Defibrinated Horse Blood Product Portfolio
  54. 8.9.5 HemoStat Laboratories Recent Developments
  55. 8.10 EWC Diagnostics
  56. 8.10.1 EWC Diagnostics Company Information
  57. 8.10.2 EWC Diagnostics Business Overview
  58. 8.10.3 EWC Diagnostics Defibrinated Horse Blood Sales, Value and Gross Margin (2021-2026)
  59. 8.10.4 EWC Diagnostics Defibrinated Horse Blood Product Portfolio
  60. 8.10.5 EWC Diagnostics Recent Developments
  61. 8.11 Dutscher
  62. 8.11.1 Dutscher Company Information
  63. 8.11.2 Dutscher Business Overview
  64. 8.11.3 Dutscher Defibrinated Horse Blood Sales, Value and Gross Margin (2021-2026)
  65. 8.11.4 Dutscher Defibrinated Horse Blood Product Portfolio
  66. 8.11.5 Dutscher Recent Developments
  67. 8.12 Serana Europe
  68. 8.12.1 Serana Europe Company Information
  69. 8.12.2 Serana Europe Business Overview
  70. 8.12.3 Serana Europe Defibrinated Horse Blood Sales, Value and Gross Margin (2021-2026)
  71. 8.12.4 Serana Europe Defibrinated Horse Blood Product Portfolio
  72. 8.12.5 Serana Europe Recent Developments
  73. 8.13 Kraeber & Co. GmbH
  74. 8.13.1 Kraeber & Co. GmbH Company Information
  75. 8.13.2 Kraeber & Co. GmbH Business Overview
  76. 8.13.3 Kraeber & Co. GmbH Defibrinated Horse Blood Sales, Value and Gross Margin (2021-2026)
  77. 8.13.4 Kraeber & Co. GmbH Defibrinated Horse Blood Product Portfolio
  78. 8.13.5 Kraeber & Co. GmbH Recent Developments
  79. 8.14 Bio Nutrientes Do Brasil Ltda.
  80. 8.14.1 Bio Nutrientes Do Brasil Ltda. Company Information
  81. 8.14.2 Bio Nutrientes Do Brasil Ltda. Business Overview
  82. 8.14.3 Bio Nutrientes Do Brasil Ltda. Defibrinated Horse Blood Sales, Value and Gross Margin (2021-2026)
  83. 8.14.4 Bio Nutrientes Do Brasil Ltda. Defibrinated Horse Blood Product Portfolio
  84. 8.14.5 Bio Nutrientes Do Brasil Ltda. Recent Developments
  85. 8.15 Lampire Biological Laboratories, Inc.
  86. 8.15.1 Lampire Biological Laboratories, Inc. Company Information
  87. 8.15.2 Lampire Biological Laboratories, Inc. Business Overview
  88. 8.15.3 Lampire Biological Laboratories, Inc. Defibrinated Horse Blood Sales, Value and Gross Margin (2021-2026)
  89. 8.15.4 Lampire Biological Laboratories, Inc. Defibrinated Horse Blood Product Portfolio
  90. 8.15.5 Lampire Biological Laboratories, Inc. Recent Developments
  91. 8.16 Innovative Research Inc
  92. 8.16.1 Innovative Research Inc Company Information
  93. 8.16.2 Innovative Research Inc Business Overview
  94. 8.16.3 Innovative Research Inc Defibrinated Horse Blood Sales, Value and Gross Margin (2021-2026)
  95. 8.16.4 Innovative Research Inc Defibrinated Horse Blood Product Portfolio
  96. 8.16.5 Innovative Research Inc Recent Developments
  97. 8.17 Colorado Serum
  98. 8.17.1 Colorado Serum Company Information
  99. 8.17.2 Colorado Serum Business Overview
  100. 8.17.3 Colorado Serum Defibrinated Horse Blood Sales, Value and Gross Margin (2021-2026)
  101. 8.17.4 Colorado Serum Defibrinated Horse Blood Product Portfolio
  102. 8.17.5 Colorado Serum Recent Developments
  103. 8.18 SSI Diagnostica
  104. 8.18.1 SSI Diagnostica Company Information
  105. 8.18.2 SSI Diagnostica Business Overview
  106. 8.18.3 SSI Diagnostica Defibrinated Horse Blood Sales, Value and Gross Margin (2021-2026)
  107. 8.18.4 SSI Diagnostica Defibrinated Horse Blood Product Portfolio
  108. 8.18.5 SSI Diagnostica Recent Developments
  109. 8.19 SR Group
  110. 8.19.1 SR Group Company Information
  111. 8.19.2 SR Group Business Overview
  112. 8.19.3 SR Group Defibrinated Horse Blood Sales, Value and Gross Margin (2021-2026)
  113. 8.19.4 SR Group Defibrinated Horse Blood Product Portfolio
  114. 8.19.5 SR Group Recent Developments
  115. 8.20 Szabo-Scandic
  116. 8.20.1 Szabo-Scandic Company Information
  117. 8.20.2 Szabo-Scandic Business Overview
  118. 8.20.3 Szabo-Scandic Defibrinated Horse Blood Sales, Value and Gross Margin (2021-2026)
  119. 8.20.4 Szabo-Scandic Defibrinated Horse Blood Product Portfolio
  120. 8.20.5 Szabo-Scandic Recent Developments
  121. 8.21 Rockland Immunochemicals, Inc.
  122. 8.21.1 Rockland Immunochemicals, Inc. Company Information
  123. 8.21.2 Rockland Immunochemicals, Inc. Business Overview
  124. 8.21.3 Rockland Immunochemicals, Inc. Defibrinated Horse Blood Sales, Value and Gross Margin (2021-2026)
  125. 8.21.4 Rockland Immunochemicals, Inc. Defibrinated Horse Blood Product Portfolio
  126. 8.21.5 Rockland Immunochemicals, Inc. Recent Developments
  127. 8.22 LABone Scientific Co.Ltd.
  128. 8.22.1 LABone Scientific Co.Ltd. Company Information
  129. 8.22.2 LABone Scientific Co.Ltd. Business Overview
  130. 8.22.3 LABone Scientific Co.Ltd. Defibrinated Horse Blood Sales, Value and Gross Margin (2021-2026)
  131. 8.22.4 LABone Scientific Co.Ltd. Defibrinated Horse Blood Product Portfolio
  132. 8.22.5 LABone Scientific Co.Ltd. Recent Developments
  133. 8.23 Quad Five(Materials Bio Inc.)
  134. 8.23.1 Quad Five(Materials Bio Inc.) Company Information
  135. 8.23.2 Quad Five(Materials Bio Inc.) Business Overview
  136. 8.23.3 Quad Five(Materials Bio Inc.) Defibrinated Horse Blood Sales, Value and Gross Margin (2021-2026)
  137. 8.23.4 Quad Five(Materials Bio Inc.) Defibrinated Horse Blood Product Portfolio
  138. 8.23.5 Quad Five(Materials Bio Inc.) Recent Developments
  139. 8.24 Guangzhou Ruite Biotechnology Co., Ltd.
  140. 8.24.1 Guangzhou Ruite Biotechnology Co., Ltd. Company Information
  141. 8.24.2 Guangzhou Ruite Biotechnology Co., Ltd. Business Overview
  142. 8.24.3 Guangzhou Ruite Biotechnology Co., Ltd. Defibrinated Horse Blood Sales, Value and Gross Margin (2021-2026)
  143. 8.24.4 Guangzhou Ruite Biotechnology Co., Ltd. Defibrinated Horse Blood Product Portfolio
  144. 8.24.5 Guangzhou Ruite Biotechnology Co., Ltd. Recent Developments
  145. 8.25 Obio Technology (Shanghai) Corp., Ltd.
  146. 8.25.1 Obio Technology (Shanghai) Corp., Ltd. Company Information
  147. 8.25.2 Obio Technology (Shanghai) Corp., Ltd. Business Overview
  148. 8.25.3 Obio Technology (Shanghai) Corp., Ltd. Defibrinated Horse Blood Sales, Value and Gross Margin (2021-2026)
  149. 8.25.4 Obio Technology (Shanghai) Corp., Ltd. Defibrinated Horse Blood Product Portfolio
  150. 8.25.5 Obio Technology (Shanghai) Corp., Ltd. Recent Developments
  151. 8.26 Beijing Solarbio Science & Technology Co.,Ltd.
  152. 8.26.1 Beijing Solarbio Science & Technology Co.,Ltd. Company Information
  153. 8.26.2 Beijing Solarbio Science & Technology Co.,Ltd. Business Overview
  154. 8.26.3 Beijing Solarbio Science & Technology Co.,Ltd. Defibrinated Horse Blood Sales, Value and Gross Margin (2021-2026)
  155. 8.26.4 Beijing Solarbio Science & Technology Co.,Ltd. Defibrinated Horse Blood Product Portfolio
  156. 8.26.5 Beijing Solarbio Science & Technology Co.,Ltd. Recent Developments
  157. 8.27 Nanjing SenBeiJia Biological Technology Co., Ltd.
  158. 8.27.1 Nanjing SenBeiJia Biological Technology Co., Ltd. Company Information
  159. 8.27.2 Nanjing SenBeiJia Biological Technology Co., Ltd. Business Overview
  160. 8.27.3 Nanjing SenBeiJia Biological Technology Co., Ltd. Defibrinated Horse Blood Sales, Value and Gross Margin (2021-2026)
  161. 8.27.4 Nanjing SenBeiJia Biological Technology Co., Ltd. Defibrinated Horse Blood Product Portfolio
  162. 8.27.5 Nanjing SenBeiJia Biological Technology Co., Ltd. Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Defibrinated Horse Blood Value Chain Analysis
  2. 9.1.1 Defibrinated Horse Blood Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Defibrinated Horse Blood Sales Mode & Process
  6. 9.2 Defibrinated Horse Blood Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Defibrinated Horse Blood Distributors
  9. 9.2.3 Defibrinated Horse Blood Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst